Resources from the same session
Emerging molecular profiling models for advanced endometrial cancer: Prognosticators and predictors of benefit from IO and targeted therapeutics
Presenter: Tjalling Bosse
Session: ESMO Colloquium supported by Eisai Europe Ltd. - Management of patients with advanced endometrial cancer in the era of molecular oncology and immunotherapy
Resources:
Webcast
The landscape of approved immune checkpoint inhibitors and TKI combinations in advanced endometrial cancer
Presenter: Vicky Makker
Session: ESMO Colloquium supported by Eisai Europe Ltd. - Management of patients with advanced endometrial cancer in the era of molecular oncology and immunotherapy
Resources:
Webcast
Research insights: New immunotherapy combinations in clinical development for gynecological malignancies
Presenter: Alexandra Leary
Session: ESMO Colloquium supported by Eisai Europe Ltd. - Management of patients with advanced endometrial cancer in the era of molecular oncology and immunotherapy
Resources:
Webcast
Q&A
Presenter: All Speakers
Session: ESMO Colloquium supported by Eisai Europe Ltd. - Management of patients with advanced endometrial cancer in the era of molecular oncology and immunotherapy
Resources:
Webcast
Concluding remarks
Presenter: Alexandra Leary
Session: ESMO Colloquium supported by Eisai Europe Ltd. - Management of patients with advanced endometrial cancer in the era of molecular oncology and immunotherapy
Resources:
Webcast